Bio-Rad Laboratories Return on Tangible Equity 2010-2023 | BIO.B
Current and historical return on tangible equity values for Bio-Rad Laboratories (BIO.B) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Bio-Rad Laboratories Return On Tangible Equity Historical Data |
| Date |
TTM Net Income |
Tangible Equity |
Return on Tangible Equity |
| 2023-03-31 |
$-0.19B |
$9.03B |
-2.25% |
| 2022-12-31 |
$-3.63B |
$8.88B |
-42.01% |
| 2022-09-30 |
$-6.02B |
$7.73B |
-62.19% |
| 2022-06-30 |
$-1.93B |
$8.34B |
-16.84% |
| 2022-03-31 |
$-0.09B |
$9.59B |
-0.74% |
| 2021-12-31 |
$4.25B |
$13.08B |
34.59% |
| 2021-09-30 |
$6.67B |
$14.86B |
58.61% |
| 2021-06-30 |
$4.05B |
$11.12B |
41.61% |
| 2021-03-31 |
$4.11B |
$10.13B |
47.33% |
| 2020-12-31 |
$3.81B |
$9.39B |
50.09% |
| 2020-09-30 |
$3.52B |
$8.33B |
53.30% |
| 2020-06-30 |
$1.95B |
$6.85B |
34.13% |
| 2020-03-31 |
$1.58B |
$5.89B |
29.96% |
| 2019-12-31 |
$1.76B |
$5.35B |
35.73% |
| 2019-09-30 |
$0.38B |
$4.72B |
8.35% |
| 2019-06-30 |
$0.90B |
$5.12B |
20.62% |
| 2019-03-31 |
$0.57B |
$4.49B |
13.98% |
| 2018-12-31 |
$0.37B |
$3.67B |
9.30% |
| 2018-09-30 |
$1.28B |
$4.25B |
35.75% |
| 2018-06-30 |
$1.03B |
$3.98B |
33.80% |
| 2018-03-31 |
$0.77B |
$3.81B |
29.78% |
| 2017-12-31 |
$0.12B |
$2.25B |
5.75% |
| 2017-09-30 |
$0.02B |
$2.15B |
0.78% |
| 2017-06-30 |
$0.01B |
$2.10B |
0.60% |
| 2017-03-31 |
$0.03B |
$2.00B |
1.28% |
| 2016-12-31 |
$0.03B |
$1.94B |
1.32% |
| 2016-09-30 |
$0.09B |
$1.98B |
5.06% |
| 2016-06-30 |
$0.09B |
$1.88B |
5.20% |
| 2016-03-31 |
$0.10B |
$1.79B |
5.99% |
| 2015-12-31 |
$0.11B |
$1.78B |
6.67% |
| 2015-09-30 |
$0.10B |
$1.70B |
6.59% |
| 2015-06-30 |
$0.10B |
$1.61B |
6.60% |
| 2015-03-31 |
$0.10B |
$1.45B |
7.10% |
| 2014-12-31 |
$0.09B |
$1.43B |
6.32% |
| 2014-09-30 |
$0.08B |
$1.39B |
5.71% |
| 2014-06-30 |
$0.06B |
$1.42B |
4.42% |
| 2014-03-31 |
$0.07B |
$1.46B |
4.74% |
| 2013-12-31 |
$0.08B |
$1.40B |
5.92% |
| 2013-09-30 |
$0.09B |
$1.33B |
7.10% |
| 2013-06-30 |
$0.14B |
$1.29B |
11.35% |
| 2013-03-31 |
$0.15B |
$1.24B |
12.77% |
| 2012-12-31 |
$0.17B |
$1.26B |
14.09% |
| 2012-09-30 |
$0.18B |
$1.18B |
16.40% |
| 2012-06-30 |
$0.19B |
$1.15B |
16.80% |
| 2012-03-31 |
$0.18B |
$1.10B |
16.12% |
| 2011-12-31 |
$0.18B |
$1.02B |
16.52% |
| 2011-09-30 |
$0.19B |
$1.14B |
17.43% |
| 2011-06-30 |
$0.19B |
$1.13B |
18.51% |
| 2011-03-31 |
$0.18B |
$1.05B |
20.10% |
| 2010-12-31 |
$0.19B |
$0.97B |
22.09% |
| 2010-09-30 |
$0.16B |
$0.87B |
19.86% |
| 2010-06-30 |
$0.15B |
$0.77B |
20.30% |
| 2010-03-31 |
$0.15B |
$0.75B |
21.61% |
| 2009-12-31 |
$0.15B |
$0.75B |
22.62% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$11.071B |
$2.802B |
|
BIO-RAD LABORATORIES, INC. manufactures and supplies to life sciences research, healthcare, analytical chemistry, semiconductor and other markets a broad range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components.
|
